Total Payments
$1.1M
2024 Payments
$58,336
Companies
49
Transactions
2,965
Medicare Patients
16,776
Medicare Billing
$8.2M
Payment Breakdown by Category
Other$793,093 (74.7%)
Travel$111,898 (10.5%)
Consulting$109,811 (10.3%)
Food & Beverage$46,158 (4.3%)
Education$888.61 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $791,893 | 375 | 74.6% |
| Travel and Lodging | $111,898 | 533 | 10.5% |
| Consulting Fee | $109,811 | 47 | 10.3% |
| Food and Beverage | $46,158 | 1,993 | 4.3% |
| Honoraria | $1,200 | 1 | 0.1% |
| Education | $888.61 | 15 | 0.1% |
| Unspecified | $0 | 1 | 0.0% |
Payments by Type
General
$1.1M
2,964 transactions
Ownership
$0
1 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lilly USA, LLC | $374,330 | 628 | $0 (2024) |
| Janssen Scientific Affairs, LLC | $248,425 | 188 | $0 (2024) |
| UCB, Inc. | $125,162 | 400 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $59,596 | 177 | $0 (2024) |
| Janssen Biotech, Inc. | $57,630 | 172 | $0 (2024) |
| GENZYME CORPORATION | $49,645 | 61 | $0 (2024) |
| PFIZER INC. | $47,041 | 297 | $0 (2024) |
| GlaxoSmithKline, LLC. | $32,654 | 81 | $0 (2024) |
| Genentech USA, Inc. | $28,136 | 89 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $10,787 | 14 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $58,336 | 266 | Janssen Biotech, Inc. ($29,421) |
| 2023 | $106,906 | 318 | Lilly USA, LLC ($48,128) |
| 2022 | $82,141 | 308 | Lilly USA, LLC ($31,818) |
| 2021 | $73,128 | 253 | Lilly USA, LLC ($30,721) |
| 2020 | $79,865 | 291 | Lilly USA, LLC ($41,010) |
| 2019 | $247,460 | 577 | Lilly USA, LLC ($91,691) |
| 2018 | $229,141 | 530 | Lilly USA, LLC ($102,334) |
| 2017 | $184,872 | 422 | Janssen Scientific Affairs, LLC ($93,111) |
All Payment Transactions
2,965 individual payment records from CMS Open Payments — Page 1 of 119
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $20.62 | General |
| Category: IMMUNOLOGY | ||||||
| 12/23/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $15.38 | General |
| Category: Immunology | ||||||
| 12/18/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $10.26 | General |
| Category: IMMUNOLOGY | ||||||
| 12/17/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $27.49 | General |
| Category: Immunology | ||||||
| 12/17/2024 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $10.76 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 12/16/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $13.62 | General |
| Category: Immunology | ||||||
| 12/14/2024 | Janssen Scientific Affairs, LLC | TREMFYA (Drug) | Consulting Fee | Cash or cash equivalent | $2,565.00 | General |
| Category: Immunology | ||||||
| 12/13/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $21.57 | General |
| Category: Inflammation/Rare Disease | ||||||
| 12/13/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $2.35 | General |
| Category: Inflammation/Rare Disease | ||||||
| 12/11/2024 | Fresenius Kabi USA, LLC | — | Food and Beverage | In-kind items and services | $22.33 | General |
| 12/10/2024 | E.R. Squibb & Sons, L.L.C. | ORENCIA (Biological) | Food and Beverage | Cash or cash equivalent | $25.30 | General |
| Category: Immunology | ||||||
| 12/10/2024 | Janssen Biotech, Inc. | SIMPONI ARIA (Biological), TREMFYA, REMICADE | Food and Beverage | In-kind items and services | $21.88 | General |
| Category: Immunology | ||||||
| 12/09/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $18.31 | General |
| Category: IMMUNOLOGY | ||||||
| 12/05/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $15.20 | General |
| Category: Immunology | ||||||
| 12/03/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $26.68 | General |
| Category: Inflammation | ||||||
| 12/02/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $30.69 | General |
| Category: IMMUNOLOGY | ||||||
| 11/27/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $22.57 | General |
| Category: Dermatology | ||||||
| 11/26/2024 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $18.46 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 11/25/2024 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $22.39 | General |
| Category: IMMUNOLOGY | ||||||
| 11/22/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $16.50 | General |
| Category: Immunology | ||||||
| 11/19/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $13.97 | General |
| Category: IMMUNOLOGY | ||||||
| 11/19/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $12.93 | General |
| Category: Bone Health | ||||||
| 11/16/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $123.59 | General |
| Category: Immunology | ||||||
| 11/15/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $16.47 | General |
| Category: IMMUNOLOGY | ||||||
| 11/14/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $1.32 | General |
| Category: Dermatology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 36 | 4,408 | 190,542 | $5.5M | $1.9M |
| 2022 | 33 | 2,977 | 142,188 | $4.6M | $1.7M |
| 2021 | 32 | 2,999 | 124,867 | $4.6M | $2.1M |
| 2020 | 61 | 6,392 | 174,293 | $4.9M | $2.5M |
Total Patients
16,776
Total Services
631,890
Medicare Billing
$8.2M
Procedure Codes
162
All Medicare Procedures & Services
162 procedure records from CMS Medicare Utilization — Page 1 of 7
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 2023 | 40 | 16,050 | $959,790 | $540,277 | 56.3% |
| J1602 | Injection, golimumab, 1 mg, for intravenous use | Office | 2023 | 51 | 32,241 | $1.5M | $338,060 | 23.3% |
| J0717 | Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 2023 | 24 | 69,600 | $1.0M | $271,623 | 26.0% |
| J3262 | Injection, tocilizumab, 1 mg | Office | 2023 | 11 | 44,436 | $355,488 | $207,373 | 58.3% |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | Office | 2023 | 37 | 7,610 | $761,000 | $197,619 | 26.0% |
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 60 | 6,060 | $155,160 | $110,362 | 71.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 355 | 1,033 | $175,610 | $90,007 | 51.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 343 | 662 | $79,440 | $39,738 | 50.0% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 58 | 302 | $75,500 | $28,429 | 37.7% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 233 | 494 | $70,170 | $23,515 | 33.5% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 133 | 487 | $60,875 | $22,203 | 36.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 535 | 1,385 | $13,406 | $11,260 | 84.0% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 413 | 618 | $15,450 | $6,293 | 40.7% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 88 | 500 | $20,000 | $5,268 | 26.3% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 289 | 6,402 | $32,010 | $5,064 | 15.8% |
| 96415 | Administration of chemotherapy into vein, each additional hour | Office | 2023 | 43 | 230 | $23,000 | $4,775 | 20.8% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 412 | 622 | $15,550 | $4,658 | 30.0% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2023 | 133 | 133 | $29,925 | $4,633 | 15.5% |
| 20552 | Injection of trigger points, 1-2 muscles | Office | 2023 | 112 | 163 | $16,300 | $4,510 | 27.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 33 | 33 | $8,580 | $3,758 | 43.8% |
| 73120 | X-ray of hand, 2 views | Office | 2023 | 66 | 116 | $5,220 | $2,541 | 48.7% |
| 73564 | X-ray of knee, 4 or more views | Office | 2023 | 48 | 73 | $5,110 | $2,205 | 43.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 30 | 30 | $5,100 | $2,120 | 41.6% |
| 73630 | X-ray of foot, minimum of 3 views | Office | 2023 | 46 | 78 | $4,290 | $1,874 | 43.7% |
| J3489 | Injection, zoledronic acid, 1 mg | Office | 2023 | 45 | 225 | $45,000 | $1,409 | 3.1% |
About Dr. Joseph Huffstutter, M.D
Dr. Joseph Huffstutter, M.D is a Rheumatology healthcare provider based in Hixson, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/15/2006. The National Provider Identifier (NPI) number assigned to this provider is 1902840788.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Joseph Huffstutter, M.D has received a total of $1.1M in payments from pharmaceutical and medical device companies, with $58,336 received in 2024. These payments were reported across 2,965 transactions from 49 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($791,893).
As a Medicare-enrolled provider, Huffstutter has provided services to 16,776 Medicare beneficiaries, totaling 631,890 services with total Medicare billing of $8.2M. Data is available for 4 years (2020–2023), covering 162 distinct procedure/service records.
Ad
Practice Information
- Specialty Rheumatology
- Location Hixson, TN
- Active Since 06/15/2006
- Last Updated 03/24/2021
- Taxonomy Code 207RR0500X
- Entity Type Individual
- NPI Number 1902840788
Products in Payments
- TALTZ (Drug) $210,636
- STELARA (Biological) $172,775
- Cimzia (Drug) $117,087
- SIMPONI ARIA (Biological) $68,736
- COSENTYX (Biological) $58,986
- OLUMIANT (Drug) $56,186
- TREMFYA (Drug) $44,737
- XELJANZ (Drug) $33,368
- BENLYSTA (Biological) $32,532
- KEVZARA (Biological) $31,423
- Actemra (Biological) $23,824
- KEVZARA (Drug) $15,331
- KEVZARA SARILUMAB INJECTION (Biological) $9,674
- INFLECTRA (Biological) $8,826
- ORENCIA (Biological) $5,792
- KRYSTEXXA (Biological) $2,317
- RINVOQ (Biological) $2,155
- Enbrel (Biological) $1,688
- Bimzelx (Biological) $1,012
- REMICADE (Biological) $945.61
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Rheumatology Doctors in Hixson
Dr. Alan Elliott, Md, MD
Rheumatology — Payments: $21,563
Rheumatology $21,563
Dr. Jessica Huffstutter, Md, MD
Rheumatology — Payments: $13,059
Rheumatology $13,059
Charles Sienknecht, M.d, M.D
Rheumatology — Payments: $3,798
Rheumatology $3,798
John Paty, M.d, M.D
Rheumatology — Payments: $12.66
Rheumatology $12.66